× We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click our cookies policy for information on how to change your cookie settings.


meta|Evidence - COVID-19

Live meta-analysis and evidence synthesis of therapies for COVID19

tutorial video
En     Fr

Our approach
   

more details ...

Network meta-analysis estimations pool direct and indirect evidences. These results should be considered as exploratory given the absence of assessment of transitivity assumption plausibility. Calculations by netmeta package.

Interactive explorer of NMA results

1Tang X, 20201NIH NIAID ACTT-1, 2020control vs. corticosteroids 1.02 [0.98; 1.07]1.02 [0.98;1.07]control vs. corticosteroids 1.02 [0.98; 1.07]control vs. remdesivir remdesivir better 1.82 [1.20; 2.76]1.82 [1.20;2.76]control vs. remdesivir remdesivir better 1.82 [1.20; 2.76]corticosteroids vs. control 0.98 [0.93; 1.02]0.98 [0.93;1.02]corticosteroids vs. control 0.98 [0.93; 1.02]corticosteroids vs. remdesivir remdesivir better 1.78 [1.17; 2.70]1.78 [1.17;2.70]corticosteroids vs. remdesivir remdesivir better 1.78 [1.17; 2.70]remdesivir vs. control remdesivir better 0.55 [0.36; 0.84]0.55 [0.36;0.84]remdesivir vs. control remdesivir better 0.55 [0.36; 0.84]remdesivir vs. corticosteroids remdesivir better 0.56 [0.37; 0.86]0.56 [0.37;0.86]remdesivir vs. corticosteroids remdesivir better 0.56 [0.37; 0.86]corticosteroidsremdesivirhydroxychloroquineconvalescent plasma treatmentinterferontocilizumab sarilumabcolchicineivermectincontroldirect evidencenetwork meta-analysis

Click on treatment name to display related network evidence

T vs. C corticosteroidsremdesivirhydroxychloroquineconvalescent plasma treatmentinterferontocilizumab sarilumabcolchicineivermectincontrol
corticosteroids---1.78
1.17; 2.70
NANANANANANANA0.98
0.93; 1.02
remdesivir0.56
0.37; 0.86
---NANANANANANANA0.55
0.36; 0.84
hydroxychloroquineNANA---NANANANANANANA
convalescent plasma treatmentNANANA---NANANANANANA
interferonNANANANA---NANANANANA
tocilizumab NANANANANA---NANANANA
sarilumabNANANANANANA---NANANA
colchicineNANANANANANANA---NANA
ivermectinNANANANANANANANA---NA
control1.02
0.98; 1.07
1.82
1.20; 2.76
NANANANANANANA---

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N) and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

   

- About - Our approach - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons